Free Trial

Takeda Pharmaceutical (TAK) News Today

$13.02
-0.04 (-0.31%)
(As of 05:32 PM ET)
Takeda Pharmaceutical Company Limited (NYSE:TAK) Shares Bought by Brandes Investment Partners LP
Brandes Investment Partners LP grew its holdings in shares of Takeda Pharmaceutical Company Limited (NYSE:TAK - Free Report) by 47.1% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 2,651,265 shares of the c
Takeda Pharmaceutical (NYSE:TAK) Reaches New 1-Year Low at $12.77
Takeda Pharmaceutical (NYSE:TAK) Hits New 12-Month Low at $12.77
Takeda Pharmaceutical (TAK) Set to Announce Earnings on Thursday
Takeda Pharmaceutical (NYSE:TAK) will be releasing earnings before the market opens on Thursday, May 9, Zacks reports.
Y.D. More Investments Ltd Has $17.90 Million Holdings in Takeda Pharmaceutical Company Limited (NYSE:TAK)
Y.D. More Investments Ltd cut its stake in Takeda Pharmaceutical Company Limited (NYSE:TAK - Free Report) by 9.2% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 1,254,591 shares of the company'
abrdn plc Takes Position in Takeda Pharmaceutical Company Limited (NYSE:TAK)
abrdn plc purchased a new position in shares of Takeda Pharmaceutical Company Limited (NYSE:TAK - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 105,073 shares of the compa
Takeda Pharmaceutical Company Limited (NYSE:TAK) Short Interest Down 26.5% in April
Takeda Pharmaceutical Company Limited (NYSE:TAK - Get Free Report) was the target of a significant decrease in short interest in April. As of April 15th, there was short interest totalling 5,970,000 shares, a decrease of 26.5% from the March 31st total of 8,120,000 shares. Based on an average daily volume of 1,850,000 shares, the days-to-cover ratio is presently 3.2 days. Currently, 0.2% of the company's stock are short sold.
Takeda Reports Positive CHMP Opinion For Fruquintinib - Quick Facts
Federated Hermes Inc. Has $6.26 Million Stake in Takeda Pharmaceutical Company Limited (NYSE:TAK)
Federated Hermes Inc. reduced its position in Takeda Pharmaceutical Company Limited (NYSE:TAK - Free Report) by 22.3% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 438,324 shares of the company's stock after selling 125,449 shares during the period. Federated
Takeda Pharmaceutical (NYSE:TAK) Reaches New 12-Month Low at $13.08
Takeda Pharmaceutical (NYSE:TAK) Hits New 12-Month Low at $13.08
Takeda Pharmaceutical Company Limited (4502.T)
Takeda Pharmaceutical (NYSE:TAK) Hits New 52-Week Low at $13.19
Takeda Pharmaceutical (NYSE:TAK) Hits New 1-Year Low at $13.19
Pacer Advisors Inc. Sells 897,979 Shares of Takeda Pharmaceutical Company Limited (NYSE:TAK)
Pacer Advisors Inc. lessened its holdings in shares of Takeda Pharmaceutical Company Limited (NYSE:TAK - Free Report) by 96.9% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 28,766 shares of the company's stock after selling 8
Takeda Pharmaceutical Company Limited (NYSE:TAK) is XY Capital Ltd's 3rd Largest Position
XY Capital Ltd increased its holdings in Takeda Pharmaceutical Company Limited (NYSE:TAK - Free Report) by 432.5% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 765,137 shares of the company's stock after buying an
Takeda Pharmaceutical (NYSE:TAK) Trading Down 2.4%
Takeda Pharmaceutical (NYSE:TAK) Stock Price Down 2.4%
Takeda Pharmaceutical Company Limited (NYSE:TAK) Short Interest Update
Takeda Pharmaceutical Company Limited (NYSE:TAK - Get Free Report) saw a large drop in short interest during the month of February. As of February 29th, there was short interest totalling 6,260,000 shares, a drop of 21.7% from the February 14th total of 7,990,000 shares. Based on an average daily volume of 1,880,000 shares, the days-to-cover ratio is currently 3.3 days. Approximately 0.2% of the company's shares are short sold.
Get Takeda Pharmaceutical News Delivered to You Automatically

Sign up to receive the latest news and ratings for TAK and its competitors with MarketBeat's FREE daily newsletter.

Tech GIANT’s Plans to Revolutionize Crypto… (Ad)

A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.

Claim your free seat by clicking here now.

TAK Media Mentions By Week

TAK Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

TAK
News Sentiment

0.39

0.44

Average
Medical
News Sentiment

TAK News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

TAK Articles
This Week

2

5

TAK Articles
Average Week

Get Takeda Pharmaceutical News Delivered to You Automatically

Sign up to receive the latest news and ratings for TAK and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NYSE:TAK) was last updated on 5/23/2024 by MarketBeat.com Staff

From Our Partners